Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(Aldactone)
9,816 results
  • A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea. [Review]
    J Menopausal Med. 2022 Dec; 28(3):92-102.Oh JW, Yun Y, Lee ES
  • Recently, gender-affirming hormone therapy for gender incongruence has become an issue in various countries and organizations with various guidelines. In South Korea, several clinical treatments are also used with many possible options. These treatments include masculinizing (female-to-male [FTM]) or feminizing (male-to-female [MTF]) hormone therapies, with regimens usually driven by standards of…
  • Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). [Journal Article]
    Am J Cardiol. 2023 Jan 10; 191:39-42.Ferreira JP, Cleland JGF, … Zannad F
  • The QRS duration can be easily obtained from a 12-lead electrocardiogram. Increased QRS duration reflects greater ventricular activation times and often ventricular dyssynchrony. Dyssynchrony causes an impairment of the global cardiac function and adversely affects the prognosis of patients with heart failure (HF). Little is known about the impact of pharmacologic therapies on the QRS duration, p…
  • Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. [Review]
    J Clin Med. 2022 Dec 21; 12(1)Reiser E, Lanbach J, … Toth B
  • Menstrual irregularities are one of the main clinical symptoms caused by polycystic ovary syndrome (PCOS). Pharmacological treatment options for non-fertility indications to restore menstrual frequency play an important role in the management of PCOS. Oral contraceptive pills are commonly prescribed for adolescents with menstrual irregularities, however, when contraindicated or poorly tolerated, …
  • Diuretics in pediatrics. [Review]
    Eur J Pediatr. 2023 Jan 03 [Online ahead of print]Lava SAG, Zollinger C, … Di Bernardo S
  • CONCLUSIONS: This educational review offers a didactical overview of diuretics in Pediatrics.
  • Gender confirmation hormonal treatment use in young Polish transgender binary and non-binary persons. [Journal Article]
    Endokrynol Pol. 2022; 73(6):922-927.Gawlik A, Antosz A, … Grabski B
  • CONCLUSIONS: These treatments (including pubertal blocking) seem to be rarely commenced in Poland before the age of 18 years. In adults, treatment consists mostly of either testosterone or oestradiol, and cyproterone acetate and, more seldom, spironolactone are used as antiandrogens in persons assigned male at birth. In turn, gonadotropin-releasing hormone agonists are barely used at all. Specialists need to be more aware that withholding treatment in minors with gender dysphoria is not a health-neutral option. Gonadotropin-releasing hormone agonists should also be more often considered as an alternative to cyproterone acetate in the context of long-term safety.
New Search Next